Initiating early treatment benefits patients who have not fully developed rheumatoid arthritis, but who are manifesting preliminary stages of the disease. This is what researchers from the Leiden University Medical Centre (LUMC) have reported in The Lancet. By temporarily prescribing methotrexate in the…